CRP and pneumocystosis: Compared to the controls, patients with PJP have significantly lower median lymphocyte values, longer COVID-19 disease duration, a higher cumulative dose of steroids received, higher CRP values, and a lower SARS-CoV-2 vaccination rate, although only the cumulative steroid dose received resulted to be independently associated with the risk of developing PJP.